Pharmaceuticals, Biotechnology and Life Sciences
Tick-borne encephalitis (TBE) is a viral infection, endemic to parts of Europe and Asia
If approved, the vaccine may help reduce the risk of TBE for people traveling to endemic areas, potentially including military personnel serving in these location…
ROCKVILLE, Md.–(BUSINESS WIRE)–GlycoMimetics, Inc. (Nasdaq: GLYC), today announces that it will host a conference call and webcast to report fourth quarter and year-end 2020 financial results on Tuesday, March 2, 2021, at 8:30 a.m. ET.
The dial-in n…
NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational neuromodulator product, DaxibotulinumtoxinA for Injection, to…
Provides First Quarter and Full Year 2021 Guidance
WILMINGTON, N.C.–(BUSINESS WIRE)–PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, today reported its financial results for the fourth quarter and full year ended December 3…
– Nolet serves as the Chair of Ambrx’s Audit Committee –
SAN DIEGO–(BUSINESS WIRE)–Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code to create Engineered Precision Biologics, today announced the appointment of Chris …
CAMBRIDGE, Mass.–(BUSINESS WIRE)–bluebird bio, Inc. (NASDAQ:BLUE) today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2020 and shared recent operational progress.
“For over ten years, blue…
TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, announced today that Paul Wagner, Ph.D., CEO of Forte Biosciences will be presenting at the Chardan Annual Micro…
— Management to Host Conference Call at 4:30 p.m. ET Today —
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of can…
G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents
DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by…
Five Phoenix, two Tucson firms to receive personalized learning plan, other benefits
PHOENIX–(BUSINESS WIRE)–#AI–Artificial intelligence to assist Alzheimer’s disease caregivers, rapid virus screeners, a headband to monitor for concussions, and new…